Founded in 2015 by Dr. Valentina Lyssova with the sole purpose of supplying the patients of scleroderma with a strong financial resource. The Lyssova Scleroderma Fund is dedicated to helping scleroderma patients have a better quality of life whilst coping with the debilitating disease. With immense commitment and conviction as well as an empathetic philanthropic heart, Dr. Lyssova aims to help patients in New York and beyond to cope with the myriad of medical and fiscal challenges that comes with living with scleroderma. Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. Prompt and proper diagnosis and treatment by qualified physicians may minimize the symptoms of scleroderma and lessen the chance for irreversible damage, which is fatal. It’s estimated that over 300,000 Americans have scleroderma, about one third of those people have the systemic form of scleroderma.